Strolll Raises Series A Led by IW Capital for AR Digital Therapeutics in Neurological Rehabilitation

Strolll Closes Series A Round

Strolll, a developer of digital therapeutics software using augmented reality (AR) glasses, has raised a Series A round led by IW Capital. The funding date is September 3, 2026. Additional investors include Cleveland Clinic and Future Planet Capital Regional.

What Strolll Does

Strolll develops digital therapeutics software that uses augmented reality (AR) glasses to improve movement therapy for individuals with neurological disorders such as Parkinson's disease, stroke, and Multiple Sclerosis. The platform enables immersive rehabilitation in both clinical and home settings.

By providing objective data and remote monitoring, Strolll's technology aims to personalize care and improve mobility for patients undergoing movement therapy.

Why It Matters

Neurological disorders affecting movement require consistent, personalized rehabilitation. Strolll's approach combines AR hardware with software that can be used across clinical and home environments, potentially extending therapy beyond traditional settings. The inclusion of objective data and remote monitoring may allow clinicians to track progress and adjust care plans more effectively.

Investors

• Lead investor: IW Capital
• Additional investors: Cleveland Clinic, Future Planet Capital Regional

The participation of Cleveland Clinic, a prominent healthcare organization, signals clinical interest in Strolll's platform.

Stage

The round is classified as Series A. The funding amount was not disclosed in the available data.

Acquisition Perspective

For acquirers in digital health, rehabilitation technology, or AR platforms, Strolll represents a specialized asset at the intersection of digital therapeutics and immersive hardware. Its focus on neurological movement disorders addresses a patient population with ongoing rehabilitation needs.

The involvement of Cleveland Clinic as an investor may provide validation and potential pathways for clinical adoption. Future Planet Capital Regional adds further backing.

As digital therapeutics continue to mature, platforms that demonstrate clinical utility and remote monitoring capabilities may attract strategic interest from healthcare systems, device manufacturers, and health technology companies.

Key Facts

• Company: Strolll
• Sector: Digital therapeutics, AR rehabilitation software
• Stage: Series A
• Lead investor: IW Capital
• Other investors: Cleveland Clinic, Future Planet Capital Regional
• Funding date: September 3, 2026
• Focus areas: Parkinson's disease, stroke, Multiple Sclerosis
• Platform capabilities: Immersive rehabilitation in clinical and home settings, objective data, remote monitoring, personalized care